We are pleased to announce the Top Three winners of Celgene’s 2017 Innovation Impact awards: Facing Our Risk of Cancer Empowered (FORCE), Foundation for Sarcoidosis Research and Myeloma Crowd.
This year, our generous judges also chose two runner-ups: American Gastroenterological Association and National Coalition for Cancer Survivorship (NCCS).
Facing Our Risk of Cancer Empowered (FORCE): Project DeCoDe-DEveloping COlaborative DEcision-making Guides on Hereditary Breast, Ovarian, and Related Cancers for Patients, Families and their Providers.
FORCE’s goal is to create collaborative decision-making tools to improve communication between patients, families, and healthcare providers.
Foundation for Sarcoidosis Research: SARC-ID (Sarcoidosis Institution Designation Program)
The foundation’s goal is to establish criteria by which sarcoidosis clinics can become certified as centers of excellence and develop a scorecard that tracks patients’ experiences in clinics.
Myeloma Crowd: HealthTree
Online tool/patient portal where multiple myeloma patients input their specific information and receive personally relevant treatment information such as nearby myeloma clinics, clinical trials, and treatment options.